Trials / Unknown
UnknownNCT04586114
Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19
Effect of Early Corticosteroid Therapy on Mortality in Patient With Acute Respiratory Distress Syndrome Secondary to Covid-19
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study conducted on hospitalized patient in critical ill units in Nancy and Metz to evaluate if early corticosteroid treatment in first seven days after admission improve patients outcome in Acute Respiratory Distress Syndrome secondary to Covid-19 compared to later corticosteroid therapy or no treatment. Also comparison of acquired infection with or without corticosteroid treatment during hospitalisation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Corticosteroids and Derivatives | Any systemic corticosteroid treatment administrated during ICU stay |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2020-05-31
- Completion
- 2020-12-31
- First posted
- 2020-10-14
- Last updated
- 2020-10-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04586114. Inclusion in this directory is not an endorsement.